Stakeholders are hoping to see methadone administration flexibilities continued after the COVID-19 public health emergency, a request that could be in reach after the Biden administration said last Thursday (April 1) it will review methadone treatment policies and develop recommendations to modernize them. Jocelyn Guyer, a managing director at Manatt Health, said the Biden administration is on the right track with its recently released drug policy priorities . “I think they did an amazing job with their priority list and...